Navigation Links
A New, Unique and Unrivalled Rat/Mouse PINP Assay for Pharmaceutical, Clinical and Academic Research Organizations.
Date:1/14/2008

BOLDON, England, January 14 /PRNewswire/ -- IDS is pleased to announce that their new, unique immunoassay Rat/Mouse PINP- the first commercial EIA to allow the specific assessment of type I collagen levels in rodent specimens*, is now available.

The IDS Rat/Mouse P1NP is the first commercial EIA to allow the specific assessment of type I collagen levels in rodent specimens*. The use of this assay will aid the assessment of new osteoporosis drug candidates in pre-clinical studies and is therefore ideal for Pharmaceutical, Clinical and Academic Research Organizations alike.

The IDS Rat/Mouse PINP EIA is very flexible and measures PINP released from collagen synthesis in rats or mice (plasma or serum). The cross-reactivity with human-derived P1NP is not detectable.

The assay is very simple to perform and results are available in under 3 hours. The assay format and quality also allows one operator to perform over 160 tests per day ensuring high sample throughput and precise, sensitive results.

The combination of 8 well microtiter strips and up to 12 months shelf life also makes this kit ideal for academic researchers with low sample throughput providing quicker and more cost-effective results.

The IDS PINP EIA further expands the range what we believe to be the largest range of Bone & Cartilage Immunoassays available globally.

* Additional Information

The generation of type I collagen is a crucial step in bone formation where type I collagen is the major organic component of bone matrix. Propeptides are cleaved from both the N- and C-terminal ends of the procollagen molecule in equimolar concentrations during collagen synthesis. Thus, the quantification of N-terminal propeptide of type I procollagen (PINP) provides measurement of collagen synthesis and/or bone formation.

Contact:

Dean Hutchinson

Head of Marketing,

IDS LTD.

Telephone: +44(0)191-519-6104

Fax: +44(0)191-519-0760

E-Mail: deanh@idsltd.com


'/>"/>
SOURCE IDS Ltd
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. American M.R.I.-DOL: Small Hospitals To Turn The Camera On Themselves In Unique National Contest
2. Study Reaffirms Superiority of Trofile(TM) Assay
3. EpiCept to Present Pre-clinical Advances of Myc Oncogene Directed Drug Discovery at Assays and Cellular Targets Conference
4. Instrumentation Laboratory Receives FDA Clearance to Expand the Intended Use for HemosIL(R) D-Dimer HS Assay
5. MedAssets Supply Chain Systems Selects Siemens Medical Solutions Diagnostics for Chemistry, Automation and Immunoassay Solutions
6. Assay Designs(TM) Announces Additions to the Leadership Team
7. ProImmune Launches New MHC-Peptide Binding Assay for Class II HLA Alleles
8. Caliper Life Sciences Introduces High Throughput RNA Assay to Improve Workflow in Gene Expression Studies
9. Strativa Pharmaceuticals, the Proprietary Products Division of Par Pharmaceutical, Provides an Update on Development Status of Pafuramidine and Other in-Licensed Products
10. Schering-Plough to Webcast Presentation at Merrill Lynch Global Pharmaceutical, Biotech & Medtech Conference
11. Merrill Lynch Global Pharmaceutical, Biotech and Medtech Conference to Webcast Millennium Presentation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/4/2016)... New FDA action date of July 22, ... July 22, 2016   --> - ... - Lifitegrast has the potential to be the only ... signs and symptoms of dry eye disease in adults --> ... approved in the U.S. in the past decade indicated for the treatment of ...
(Date:2/4/2016)... Church, VA (PRWEB) , ... ... ... first-year cybersecurity conference presented by Bloomsburg University’s Digital Forensics Club, takes place ... PA. The two-day event features 20+ speakers and activities such as workshops ...
(Date:2/4/2016)... VANCOUVER, British Columbia and MENLO PARK, ... Inc. (OTCQX: DMPI) ("DelMar" and the "Company"), a biopharmaceutical ... therapies, today announced that it will present at the ... on Monday, February 8, 2016 at 10:00 a.m. EST in ... Jeffrey Bacha , DelMar,s president and CEO, will provide an ...
(Date:2/4/2016)... , Feb. 4, 2016  Spherix Incorporated (Nasdaq: ... the fostering and monetization of intellectual property, today provided ... Uniden in the Northern District of Texas ... forward.  Inter Partes Re-examination ("IPR") ... Patent Office.  The IPR was initiated on only certain ...
Breaking Biology Technology:
(Date:2/1/2016)... MELBOURNE, Fla. , Feb. 1, 2016  Wocket® smart wallet ( ... actor and television personality, Joey Fatone . Las ... and greet fans. --> Las Vegas , ... --> The new video ad was filmed at the ... Joey appeared at the Wocket booth to meet and greet fans. ...
(Date:1/25/2016)... 2016   Unisys Corporation (NYSE: UIS ) today ... (JFK) International Airport, New York City , to ... attempting to enter the United States using ... pilot testing of the system at Dulles last year. ... JFK during January 2016. --> pilot testing of ...
(Date:1/22/2016)... http://www.researchandmarkets.com/research/p74whf/global_biometrics ) ... "Global Biometrics Market in Retail Sector 2016-2020" ... --> http://www.researchandmarkets.com/research/p74whf/global_biometrics ) has announced the ... in Retail Sector 2016-2020" report to ... and Markets ( http://www.researchandmarkets.com/research/p74whf/global_biometrics ) has announced ...
Breaking Biology News(10 mins):